Clinical Trials Browser

Phase 3 × Endometrial Neoplasms × sintilimab × Clear all

NCT06584032 2025-01-07

Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer

Phase 3 Recruiting

Endometrial Neoplasms